The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma-Reference-Cited by-同舟云学术

The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma

Published:2013-09 Issue:3 Volume:258 Page:500-507
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Francis Ashleigh M.,Sepesi Boris,Correa Arlene M.,Blum Mariela A.,Erasmus Jeremy J.,Lee Jeffrey H.,Maru Dipen M.,Mehran Reza J.,Rice David C.,Roth Jack A.,Vaporciyan Ara A.,Walsh Garrett L.,Welsh James W.,Swisher Stephen G.,Hofstetter Wayne L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference11 articles.

1. Trends in esophageal cancer incidence by histology, United States, 1998-2003.;Trivers;Int J Cancer,2008

2. Cancer statistics, 2012.;Siegel;CA Cancer J Clin,2012

3. Preoperative chemoradiotherapy for esophageal or junctional cancer.;van Hagen;N Engl J Med,2012

4. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.;Sjoquist;Lancet Oncol,2011

5. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on CancerInternational Union Against Cancer Staging Manuals.;Rice;Cancer,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma;Frontiers in Oncology;2022-11-10

2. Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer;American Journal of Clinical Oncology;2022-11-02

3. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery;BMC Cancer;2021-02-03

4. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey;Human Pathology;2021-02

5. Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach;BMC Cancer;2020-09-02